A Silicon Valley engineer cracked the code to find signs of colon cancer in your blood

Guardant Health; Getty Images; Alyssa Powell/BIGuardant Health has the first FDA-approved liquid biopsy that can spot colon cancer.Co-CEO Helmy Eltoukhy tells Business Insider the story of how they used Silicon Valley strategy to build it.This article is part of "Transforming Treatments," a series on medical innovations that save time, money, or discomfort.At first, cancer is a quiet disease. Inside the body, cells are aggressively multiplying out of control, changing everything. But on the outside, there's nothing special to see or feel. Not yet.For Guardant co-CEO Helmy Eltoukhy, that invisibility looked like an engineering challenge. What if cancer could be detected early — through blood tests — before you even knew it was there?"So many patients go through this really nerve-racking diagnostic odyssey," Eltoukhy told Business Insider.Eltoukhy, who trained as an electrical engineer at Stanford during the late '90s dot-com boom, had watched classmates start companies like Google and Facebook. He took a job at Illumina, working to make genome sequencing cheaper — cutting the cost of a once-unthinkable endeavor from billions to around $1,000.It was a lesson in how Moore's Law — technology getting exponentially faster and cheaper — could transform biology, too.Guardant Health co-CEO, Helmy Eltoukhy.Guardant HealthAnd so, for the past 13 years, he's been chasing what he calls a holy grail for early disease detection: a blood test any doctor might whip out at an annual physical, to screen for all kinds of cancer.Today, he's closer than ever. With FDA approval to screen for colon cancer already locked in, he's chasing pre-cancer detection, and maybe even general organ health and blood tests for other diseases, like inflammatory issues.Still, it's unclear whether his publicly traded company will manage to turn a profit, and just how far its blood-based disease-hunting strategy can go.Engineering blood to find cancer seemed easy, until it wasn'tA drop of blood that can detect disease? I know, we've heard this tall tale before (Theranos, anyone?) Technically, it's not impossible, if done right.That's where Eltoukhy started. In 2012, he teamed up with fellow Stanford alum AmirAli Talasaz to design "liquid biopsies" — using fragments of cancer DNA in someone's blood to help doctors determine the best course of treatment.Guardant used more than a drop's worth of blood, gathering a few teaspoons, enough to fill at least two vials. The company's first "360" cancer test was a success and was approved by the FDA in 2020, helping doctors better tailor late-stage cancer treatments and improve survival.Guardant's tests usually require between two to four vials of blood to be drawn.FG Trade Latin/Getty ImagesBut the ultimate goal was spotting cancer early — perhaps even before symptoms arise. In 2015, they "hit a wall," Eltoukhy said. Just a couple of years into their project, they found "there was nothing else to detect" genetically.The company went into moonshot mode ("project LUNAR"), turning to epigenetics — the molecular "software" that controls which genes are powered on or off inside our bodies' hardware (our DNA).That was the big unlock for seeing more cancer. "We created a chemistry that allows us to see both the hardware layer (the genomics) and the software layer (the epigenetics)," Eltoukhy said.Suddenly, a whole new field of possibilities opened up.From colon cancer to 'an everything test'That breakthrough led to SHIELD, the first FDA-approved blood test for colon cancer, cleared in 2024. The test is near-perfect at detecting late-stage cancer, when there is a lot of cancer DNA being shed into a person's blood, but it is only about 60% sensitive to stage 1 cancer.It is now being tested in a massive, independent clinical trial of 24,000 patients across the US, alongside a test from competitor ClearNote Health. The goal of this "Vanguard" study from the National Institutes of Health is to measure how well Guardant's SHIELD can spot not just colon cancer but other kinds, too — bladder, breast, pancreatic, and more."Think of it as your iPhone, where initially it only had a few features, over time, it has a thousand features," Eltoukhy told Business Insider. "You imagine a future where you combine all of that in a single blood test and you're looking at not billions, but trillions or quadrillions of data points per test. It's just a matter of time. There's no doubt in my mind that that'll be in the cards for all of us." Read more from the Transforming Treatments series:A new laser hair-loss treatment aims to be like going to the dentist twice a yearWould you pay $2,500 a year to scan your entire body for hidden diseases?Colonoscopies are no fun. These at-home colon cancer screenings offer a shortcut. There's potential to detect other conditions, too. Inflammatory diseases, organ health, and biological aging are just a few of the targets Eltoukhy has his sights set on. "I think in the future it could be multi-disease," he said. "We think it could literally be an everything test that complements a primary care physician."Today, liquid biopsies, like Guardant's, are among the most sought-after investments in biotech. Earlier this year, Guardant announced one such "strategic collaboration" with Pfizer. Guardant also has numerous publicly traded competitors, including the Illumina spinoff Grail, Myriad, and Natera.Guardant is headquartered in Palo Alto, California, where co-CEO Eltoukhy went to college at Stanford.Guardant HealthDr. Eleftherios Diamandis, a clinical biochemist at the University of Toronto, has been studying the genetics of cancer since the 1980s. He says this kind of seamless cancer surveillance has always been a cancer doctor's dream, but so far, accurate early detection has remained elusive."I never say never because who knows how the science will work out in five years or 10 years," Diamandis told Business Insider. "But as we speak now with the clinical science Guardant has published and other companies have published, they are missing these lesions," he said, referring to the precancerous polyps that precede colon cancer, and that are easily cleaned out during routine colonoscopies.Diamandis wonders if we will ever be able to reliably pick out meaningful clues in our blood that predate cancer — can you see something that's not there yet?Still, he holds onto the possibility that science and technology might advance beyond what he can imagine. He never thought he'd be able to cruise through the chaos of rush hour traffic in a car that drives itself. Now, he does."The accuracy and the speed and all the difficult situations that this car can handle," he said. "I don't know how they made it. It's unbelievable."The urgencyGuardant developed the first FDA-approved blood test that screens for colon cancer. It's near-perfect at detecting late-stage colon cancer, but is only about 60% sensitive for detecting stage 1.Guardant HealthAlready, the demand for a test like SHIELD is high. Rates of colon cancer have been rising sharply among patients under 50, historically considered too young, too healthy, and too numerous for routine colonoscopies.Dawson's Creek star James Van Der Beek, who was diagnosed with colon cancer at 46 years old, told Business Insider he wishes this test had been available years earlier. (Van Der Beek is now a paid spokesperson for Guardant.)"If I could save anybody the journey that I've had to endure the last two years, man, that's a beautiful thing," Van Der Beek told Business Insider. "I mean, listen, the 'could-have, should-have' train is a black hole, and so I don't want to jump on board that, but don't let my could-haves become yours. That's my biggest message. Get screened."Read the original article on Business Insider

Comments

Business News

Brexit impact on UK economy ‘negative for foreseeable future,’ Bailey says

Independent

Comments

Business News

Brexit impact on UK economy ‘negative for foreseeable future,’ Bailey says

What To Watch This Weekend: New Shows And Movies To Stream On Netflix, Hulu, Prime Video, Apple TV And More

NYT Connections Today: Hints And Answers For Sunday, October 19 (#861)

How James Bond Can Be Reinvigorated By Amazon MGM

Formula 1 Standings 2025: Which Drivers Have The Best Shot At The Title?

Will There Be ‘The Diplomat’ Season 4? How Season 3’s Twist Ending Sets It Up

The Snobs’ Attack On Gold Is Failing, Thanks To Bitcoin

Asked About ‘Boots,’ The Pentagon Cites Netflix ‘Woke Garbage’

What Happened To Ajike Owens? The Disturbing True Story Behind ‘The Perfect Neighbor’

Paramount Skydance to cut 2,000 jobs starting final week of October: report

Developing Rosebank oil field ‘pure climate vandalism’, Scottish Green insists

Developing Rosebank oil field ‘pure climate vandalism’, Scottish Green insists

Why ‘The Diplomat’ Should Be The Model For All Netflix Shows

Mega Millions Jackpot Rises To $650 Million—Here’s How Much The Winner Could Take Home After Taxes

‘This new £7 glow-boosting skin tint instantly makes me look less tired’

The most iconic food in every state

I hadn't seen my sister for 2 years. We met in Liechtenstein to reconnect.

My stay at a luxury villa in Orlando was a wildly good value. I had a private pool and easy access to Disney World.

Regan Smith Takes Down American Record At Swimming World Cup

NFL 2025 Week 7 Fantasy Football Top DFS Single Entry And GPP Stacks

Justin Bieber Charts Another Pop Radio No. 1 — Which Superstars Does He Tie?

Sabrina Carpenter Scores New Top 10 Hits — And She Had Help From The World’s Biggest Star

‘KPop Demon Hunters’ Is Catching Up To Rosé’s Historic Radio Success

Chris Jericho Could Be Next Marquee AEW Star To Leave For WWE

Danny Garcia Vs. Daniel Gonzalez: Odds, Records, Prediction

'I've cleaned my floors three times this week after buying Shark steam mop'

DWP officials to be given power to view claimants' bank details under new law

Molly-Mae Hague's 'stunning' Tom Ford perfume is down to £5 in money-saving deal

Amazon cuts 33% off a dehumidifier recommended for 'battling condensation and damp'

Martin Lewis advice could lead to free £400 'before Christmas'

This hot chocolate advent calendar saves you £2 a day on fancy takeaway drinks

All employees urged to check 3 vital details on their payslips

'VIP airport lounge staff gave us half price - here's how to do it'

The best advice I ever got about work-life balance came from a past boyfriend's mom. It's shaped my life for 2 decades.

I visited a 'haunted' 18th-century mansion in New York City and saw things I couldn't fully explain

7 celebrities who competed at Miss USA, including Olivia Culpo and Halle Berry

Opinion: Susan Stamberg gave NPR its voice

Ofcom orders BBC to air on TV finding that Gaza film broke broadcasting rules

What The Outcome Of Trump’s Meeting With Zelensky Means For Putin

Taylor Swift Passes Ariana Grande With Her New Chart-Topping Smash

$15 Billion Bitcoin Seizure Exposes Challenges For US Crypto Reserve Strategy

From Stay-At-Home Mom To Comedy Star, How Zarna Garg Turns Punchlines Into Profits

Hit Netflix Show Returns With Peak Worldwide Interest

Saturday, October 18. Russia’s War On Ukraine: News And Information From Ukraine

The Marvel Show Which Cost Just $30 Million To Make

Rasmus Hojlund’s Napoli Revival Is A Cautionary Tale For Man United

‘I’ve resisted buying a pricey heated airer by doing this clever free trick instead’

Every Nationwide branch that's staying open until at least 2028

Martin Lewis's superb radiator hack costs less than £10 but could save tonnes on heating bills

'I was love-bombed by a Somalia doctor on Facebook - then forced into sick blood oath'

YouTube steps up its shopping game with help from influencers

11 of Taylor Swift's best lyrical burns

I got married for the first time at 76 after finding my true love. It's never too late.

The weather is finally chilly. Here's how to refresh your home for ultimate coziness.

The defense prime contractors have a new problem on their hands

Wall Street's rising stars share how they set boundaries and avoid burnout &mdash; even in one of the toughest industries

I couldn't afford my rent and student loans, so I moved in with my mom. It took me 3 years to get back on my feet.

There's one key thing companies must do when they bring AI into the workplace, BCG's AI ethics officer says

The Risk That Built America

‘Kantara’ Hindi Resurfaces On Netflix Global Top 10

Wall Street's rising stars share how they set boundaries and avoid burnout — even in one of the toughest industries